Protara Therapeutics Inc: Preliminary Data From Six-Month Evaluable Patients in Advanced-2 Trial of Tara-002 in Nmibc Expected in 2H 2024
Protara Therapeutics Inc:預計將於2024年下半年在NMIBC進行Tara-002的Advanced-2試驗中獲得爲期六個月的可評估患者的初步數據
Protara Therapeutics Inc: Preliminary Data From Six-Month Evaluable Patients in Advanced-2 Trial of Tara-002 in Nmibc Expected in 2H 2024
Protara Therapeutics Inc:預計將於2024年下半年在NMIBC進行Tara-002的Advanced-2試驗中獲得爲期六個月的可評估患者的初步數據
使用瀏覽器的分享功能,分享給你的好友吧